Search - tctmd.com

Displaying 1 - 20 of 764

Sort: Relevancy | Date

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Conference News AHA 2025

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

Todd Neale

November 08, 2025

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

Todd Neale

November 03, 2025

Presentation TCT 2025

TCT 187: Three-Year Follow-up of the First Everolimus-Coated Balloon for Patients with In-Stent Restenosis

Presenter: Fernando Alfonso

October 28, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

Presentation TCT 2025

Everolimus-Coated Balloon Intervention for Patients with In-Stent Restenosis: 3-Year Clinical Results

Presenter: Fernando Alfonso

October 26, 2025

Presentation TCT 2025

Abluminus Sirolimus DES+ vs. Everolimus-Eluting Stents in Patients with Diabetes Mellitus: Final 2-Year Results of the ABILITY Global Study

Presenter: Alexandre Abizaid

October 25, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

TCT 427: Comparison of Clinical Outcomes Between Second Generation Zotarolimus- Versus Everolimus-Eluting Stents up to 10-Year Follow-up

Presenter: Woo Jin Ahn

October 29, 2024

Presentation TCT 2024

TCT 418: Efficacy and Safety of the Bioabsorbable Polymer Everolimus-Eluting Stent in Routine Clinical Practice: Data From the IRIS-DES Registry

Presenter: Kyeong-Won Seo

October 28, 2024

Presentation TCT 2024

TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study

Presenter: Richard Pin

October 27, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

Presentation EuroPCR 2024

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

Presenter: Alexandre Abizaid

May 14, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

Advertisement

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

TCT 187: Three-Year Follow-up of the First Everolimus-Coated Balloon for Patients with In-Stent Restenosis

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Everolimus-Coated Balloon Intervention for Patients with In-Stent Restenosis: 3-Year Clinical Results

Abluminus Sirolimus DES+ vs. Everolimus-Eluting Stents in Patients with Diabetes Mellitus: Final 2-Year Results of the ABILITY Global Study

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

Top Endovascular News of 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

TCT 427: Comparison of Clinical Outcomes Between Second Generation Zotarolimus- Versus Everolimus-Eluting Stents up to 10-Year Follow-up

TCT 418: Efficacy and Safety of the Bioabsorbable Polymer Everolimus-Eluting Stent in Routine Clinical Practice: Data From the IRIS-DES Registry

TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study

DES Best for In-Stent Restenosis, but DCBs Also Viable

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

FDA Approves Bioresorbable Scaffold for BTK Lesions

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Top Endovascular News of 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content